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Abstract: A series of twenty-six methoxylated and methylated N-aryl-1-hydroxynaphthalene-
2-carboxanilides was prepared and characterized as potential anti-invasive agents. The molecular
structure of N-(2,5-dimethylphenyl)-1-hydroxynaphthalene-2-carboxamide as a model compound
was determined by single-crystal X-ray diffraction. All the analysed compounds were tested against
the reference strain Staphylococcus aureus and three clinical isolates of methicillin-resistant S. aureus
as well as against Mycobacterium tuberculosis and M. kansasii. In addition, the inhibitory profile
of photosynthetic electron transport in spinach (Spinacia oleracea L.) chloroplasts was specified.
In vitro cytotoxicity of the most effective compounds was tested on the human monocytic leukaemia
THP-1 cell line. The activities of N-(3,5-dimethylphenyl)-, N-(3-fluoro-5-methoxy-phenyl)- and
N-(3,5-dimethoxyphenyl)-1-hydroxynaphthalene-2-carbox- amide were comparable with or even
better than the commonly used standards ampicillin and isoniazid. All promising compounds
did not show any cytotoxic effect at the concentration >30 µM. Moreover, an in silico evaluation
of clogP features was performed for the entire set of the carboxamides using a range of software
lipophilicity predictors, and cross-comparison with the experimentally determined lipophilicity
(log k), in consensus lipophilicity estimation, was conducted as well. Principal component
analysis was employed to illustrate noticeable variations with respect to the molecular lipophilicity
(theoretical/experimental) and rule-of-five violations. Additionally, ligand-oriented studies for the
assessment of the three-dimensional quantitative structure–activity relationship profile were carried
out with the comparative molecular surface analysis to determine electron and/or steric factors that
potentially contribute to the biological activities of the investigated compounds.
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1. Introduction
Hydroxynaphthalenecarboxanilides demonstrated a spectrum of anti-infectious [1–8] and/or
anti-proliferative properties [9,10], as was described recently. These structurally simple compounds,
regarded as ring analogues of salicylanilides (e.g., niclosamide [11–13]), can be considered a part of the
group of privileged structures. Their activity is dependent on the mutual position of the carboxamide
and the phenolic moieties [1–3,5,8]; therefore, analogues with various positions of the phenolic motif
show a spectrum of various biological activities. The carboxamide fragment (-CONH–) mimicking a
peptide bond is crucial for the activity, because by means of this moiety a compound is bound to its
targets. In terms of the polypharmacology idea, these compounds can be classified as multi-target
compounds, since they are able to affect various target structures, especially in microbial pathogens,
similarly as salicylanilides [14–17]. It is assumed that the anilide part of the molecule is responsible
for influencing the physicochemical properties and binding strength of the tested compounds to the
potential target.
Drug design is a complex issue that is focused on the optimization of the molecular interactions
between a drug molecule and a biomolecular target. The contacted drugs or, more generally, ligands
(in Latin ‘ligare’ means ‘tie’) and macromolecules initiate the signals that control the substantial
effects of living organisms [18]. A description of the intensity of the ligand-target contacts and their
interactions require a specific representation for the proper evaluation of quantitative structure–activity
relationships (QSAR). Roughly speaking, properties and/or descriptors are two representations of
chemical compounds [19]. While properties are measured, descriptors are calculated or, more
accurately, are final results of a logic or mathematical procedure transforming the chemical information
encoded within symbolic representations of molecules into useful numbers [20]. In this context,
even a simple property vs. descriptor paradigm gets fuzzy even when a simple molecular feature
such as molecular lipophilicity is analysed. Obviously, lipophilicity can be measured using various
experimental approaches that are basically time– and/or material–consuming and require a high
purity of the solute; therefore, alternative lipophilicity descriptors have been proposed using mainly
in silico predictive models [21]. On the other hand, some methods for the theoretical calculation of
lipophilicity might be more or less suitable for specific/heterogeneous series of compounds analysed,
thus a variety of approaches should be employed with the results subsequently compared with the
empirical data [22]. The quantitative evaluation of the lipophilic characteristics is indispensable at the
stage of the generation of ADMET-tailored structure–activity relationships (SAR) models of potential
drug molecules. The concepts such as drug-likeness or Lipinski’s rule-of-five (Ro5) highlight the
molecular features that are frequently related with the term ‘property’ in drug discovery. Basically, the
aforementioned pre-filters are expected to provide a higher success ratio at the advanced development
stages based on the ‘fail-early fail-cheaply’ paradigm. Precisely speaking, these filters cannot be solely
based on the measurable properties, because in many cases the molecules that are being designed are
not accessible for empirical surveys. In consequence, the molecular descriptors need to be calculated
in order to foresee the desired substance property. Calculated lipophilicity (clogP) is the most obvious
example, since a regression model is built based on ca. 3 × 104 lipophilic measurements [23]. Probably,
the property vs. descriptor ‘play’ can be better explained when we realize that actual logP measurement
is relatively rarely conducted even if a compound is synthesized.
In the light of the above-mentioned facts, a new series methoxylated and methylated N-aryl-1-
hydroxynaphthalene-2-carboxanilides was designed and investigated for their physicochemical and
biological properties. The compounds were tested for their antistaphylococcal and antimycobacterial
activities. Additionally, their ability to inhibit photosynthetic electron transport (PET) in spinach
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(Spinacia oleracea L.) chloroplasts was evaluated, because it was found previously that antimycobacterial
activity correlates with PET inhibition profile [1–7,14,24–27]. The amide moiety is present in many
herbicides acting as PET inhibitors in photosystem (PS) II [28]. The formation of hydrogen bonds
between the CONH moiety and the target proteins in photosynthetic centres of thylakoid membranes
changes protein conformation resulting in PET inhibition. Amides were described as PS II inhibitors,
where they cause the displacement of plastoquinone (QB) from its binding pocket in one of the protein
subunits of PS II, the D1 protein [29–31].
In addition, another objective of the presented study was the in silico deduction of clogP features
for the set of N-(methoxy/methyl-phenyl)-1-hydroxynaphthalene-2-carboxamides using a range of
software lipophilicity predictors and cross-comparison with experimental lipophilicity (log k) in
consensus lipophilicity evaluation. Moreover, principal component analysis (PCA) was employed to
illustrate noticeable variations with respect to the molecular lipophilicity (theoretical/experimental) and
rule-of-five violations. Ligand-oriented studies for the assessment of the three-dimensional (3D)-QSAR
profile were performed with comparative molecular surface analysis (CoMSA) to determine the electron
and/or steric factors that potentially contribute to the biological activities of the investigated compounds.
In fact, probability-guided CoMSA modelling based on the iterative variable elimination-partial least
squares method (IVE-PLS) facilitated the visualization of the pharmacophore patterns that are
potentially valid for the activity of the analysed carboxanilides.
2. Results and Discussion
2.1. Chemistry
The reaction of 1-hydroxynaphthalene-2-carboxylic acid and an appropriate substituted aniline
with phosphorus trichloride in dry chlorobenzene under microwave conditions gave a series of
methoxylated and methylated N-aryl-1-hydroxynaphthalene-2-carboxanilides 1–26, see Scheme 1 and
Table 1. Compounds 1–4, 8–10 [1], 5–7, 11–19, 21, 22, and 24–26 [10] were published recently.
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2.2. X-ray Crystallography
The molecular structure of N-(2,5-dimethylphenyl)-1-hydroxynaphthalene-2-carboxamide (11) is
shown in Figure 1, while its crystal data and structure refinement are given in Table 2. The selected bond
lengths and angles are summarized in Table S1 in Supplementary Materials. This compound showed
in vitro antistaphylococcal activities and could be obtained in the form of single crystals suitable
for X-ray structure determination. The molecular structure of compound 11 consists of individual
molecules which are stabilized by intramolecular O–H···O hydrogen bonds (Figure S1, Table S2 in
Supplementary Materials). Moreover, the C–H···O and C–H···C non-covalent interactions connect the
individual molecules into a 3D supramolecular structure. The molecule of 11 is nearly planar. The
least-square plane fitted through all the non-H atoms of 11 revealed that the maximal deviation from
the plane has been found for the N1 atom (0.1022(23) Å). The molecule contains naphthalene and
benzene rings that are nearly coplanar with the angle of 3.014(59)◦. The bond lengths and angles
of compound 11 are of typical values and comparable with those in already published structures
involving the N-(phenyl)-naphthalene-2-carboxamide moiety, except for the C9=O2 distance (1.249(3)
Å), which is slightly influenced by the presence of the O1–H1A···O2, C5-H5A···O2 and C15–H15A···O2
non-covalent contacts. To date, 31 structures with the mentioned moiety have been deposited within
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the Cambridge Structural Database (CSD) [32] revealing the values of median C=O and N–C(O) bond
lengths of 1.227(17) Å and 1.358(32) Å, respectively.
Table 1. Compositions of N-substituted 1-hydroxynaphthalene-2-carboxanilides, experimental log
k values, in vitro antistaphylococcal activities MIC [µM] compared to ampicillin (AMP), in vitro
antimycobacterial activities MIC [µM] compared to isoniazid (INH), in vitro cytotoxicity (Tox) assay
(LD50 [µM]) of chosen compounds and IC50 [µM] values related to PET inhibition in spinach chloroplasts
compared to 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU) standard.
Comp. R log k
MIC [µM]
Tox LD50
[µM]
PET IC50
[µM]SA MRSA63718
MRSA
SA 630
MRSA
SA 3202 MT MK
1 H a 0.6769 >972 >972 243 122 486 15.2 >30 31.3
2 2-OCH3 a 0.8584 >873 >873 >873 >873 436 >873 – 199
3 3-OCH3 a 0.6713 109 >873 >873 >873 436 >873 – 23.5
4 4-OCH3 a 0.6284 873 >873 >873 >873 436 >873 – 79.5
5 2,5-OCH3 b 0.8712 791 395 395 197 396 24.7 – 201
6 3,5-OCH3 b 0.7048 12.3 24.7 24.7 24.7 24.7 24.7 >30 13.4
7 3,4,5-OCH3 b 0.5603 724 724 724 724 22.6 90.5 – 468
8 2-CH3 a 0.5650 115 231 231 231 462 115 – 62.8
9 3-CH3 a 0.8235 115 923 923 462 462 28.8 – 20.0
10 4-CH3 a 0.8294 923 923 923 923 462 57.7 – 28.7
11 2,5-CH3 b 0.7155 13.7 27.5 27.5 27.5 110 220 >30 52.4
12 2,6-CH3 b 0.5990 55.0 110 110 110 110 220 – 60.3
13 3,5-CH3 b 1.0030 3.43 6.85 6.85 6.85 6.86 27.4 >30 8.19
14 2,4,6-CH3 b 0.7477 >838 >838 >838 >838 13.1 104 – 295
15 2-OCH3-5-CH3 b 1.0603 >832 >832 >832 >832 13.0 52.0 – 588
16 2-OCH3-6-CH3 b 0.4574 >832 >832 >832 >832 52.0 104 – 747
17 2-CH3-5-OCH3 b 0.5362 52.0 832 104 208 13.0 104 – 142
18 2-OCH3-4-NO2 b 0.5434 756 756 756 756 378 756 – 495
19 2-OCH3-5-NO2 b 0.4827 756 756 756 756 378 756 – 155
20 2-OCH3-5-Br 1.0432 687 687 687 687 344 687 – 569
21 2-OCH3-5-CF3 b 0.9428 708 708 708 708 354 708 – 26.4
22 3-CF3-4-OCH3 b 0.8915 354 354 354 5.53 354 88.5 – 18.5
23 3-F-5-OCH3 0.7629 1.60 3.21 3.21 3.21 25.6 12.0 >30 10.1
24 2-Cl-5-OCH3 b 0.8130 781 781 781 781 24.4 781 – 60.9
25 2-CH3-5-CF3 b 0.7479 741 741 741 741 46.3 92.6 – 36.7
26 3-CF3-4-CH3 b 1.1411 741 741 741 741 371 741 – 16.3
AMP – – 5.72 45.8 45.8 45.8 – – – –
INH – – – – – – 36.6 233 – –
DCMU – – – – – – – – – 2.1
a described in [1], b described in [10], SA = Staphylococcus aureus ATCC 29213; MRSA = clinical isolates of
methicillin-resistant S. aureus 63718, SA 630, and SA 3202 (National Institute of Public Health, Prague, Czech
Republic); MT = Mycobacterium tuberculosis H37Ra ATCC 25177, MK = M. kansasii DSM 44162.
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Table 2. Crystal data and structure refinement for 11.
Formula C19H17NO2
Formula weight 291.33
Temperature 120(2) K
Wavelength 0.71073 Å
Crystal system Monoclinic
Space group P21/n
Unit cell dimensions a = 6.887(4) Å, α = 90◦
b = 16.134(11) Å, β = 99.81(2)◦
c = 13.620(8) Å, γ = 90◦
Volume 1491.3(15) Å3
Z 4
Density (calculated) 1.298 g/cm3
Absorption coefficient 0.084 mm−1
F(000) 616
Crystal size 0.240 × 0.200 × 0.180 mm
Theta range for data collection 1.974 to 25.074◦
Index ranges −8 ≤ h ≤ 8, −19 ≤ k ≤ 19, −16 ≤ l ≤16
Reflections collected 14255
Independent reflections 2635 [R(int) = 0.1005]
Completeness to θ 25.074◦ (99.7%)
Absorption correction Semi-empirical from equivalents
Refinement method Full-matrix least-squares on F2
Data/restraints/parameters 2635/0/201
Goodness-of-fit on F2 1.065
Final R indices [I > 2σ(I)] R1 = 0.0586, wR2 = 0.1246
R indices (all data) R1 = 0.1246, wR2 = 0.1506
Largest diff. peak and hole 0.196 and −0.228 e.Å−3
2.3. In Silico clogP Estimation and Experimental Lipophilicity Specification
The estimation of the lipophilic values for the ensemble of N-(methoxy/methyl-phenyl)-1-
hydroxynaphthalene-2-carboxamides was performed using a range of in silico logP predictors,
for instance, clogPS, Molinspirations, OSIRIS, HyperChem 7.0, Sybyl X, MarvinSketch 15,
ACD/ChemSketch 2015, Dragon6.0, Kowwin, and XlogP3. The numerical values of the theoretically
estimated partition coefficients and the empirically specified log k parameters are listed in Tables 1 and 3.
The corresponding logP estimators deduced by the set of alternative methods were (inter-)correlated
with each other and cross-compared with the experimental values as shown in Figure 2 and Table S3
(Supplementary Materials). Unfortunately, the majority of the applied programs (apart from clogPS,
Molinspirations, Sybyl X, ChemSketch, Kowwin) do not differentiate the calculated lipophilicity for
positional isomers (see Table 3). Not surprisingly, some observed variations in clogP values are probably
the consequence of different in silico principles (descriptor/atom/fragment-based) implemented in
the software and/or models applied (training datasets) [33]. Generally, a pretty high inter-correlation
(ranging from r = 0.56 to r = 0.98) within the estimated values of logP was noticed for the analysed
group of compounds as illustrated by the triangular matrix of linear correlation parameters in Figure 2.
On the other hand, relatively poor correlation between the empirical lipophilicity (log k) and theoretical
logP estimators was recorded with the best match depicted for Sybyl-X (r = 0.65) and Molinspiration
(r = 0.59) software. Strangely enough, the higher inter-correlation between calculated clogP values, the
worse cross-correlation with the experimental data. Obviously, models are as good as the training
data applied at the modelling stage; therefore, the poor predictive logP performance can be partially
elucidated by insufficient coverage of the structural space by measured compounds.
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Table 3. Theoretically estimated partition coefficient calculated by set of alternative methods for
N-(methoxy/methyl-phenyl)-1-hydroxynaphthalene-2-carboxamides 1–26.
No. logP a miLogP b ClogP c ClogP d ClogP e ClogP f ClogP g MlogP h AlogP i ClogP j ClogP k
1 3.98 4.27 3.65 3.51 4.43 3.75 4.50 3.91 3.26 4.47 4.20
2 4.27 4.28 3.58 3.25 3.93 3.59 4.40 3.61 3.24 3.99 4.17
3 4.25 4.30 3.58 3.25 4.52 3.59 4.66 3.61 3.24 4.55 4.17
4 4.23 4.33 3.58 3.25 4.52 3.59 4.45 3.61 3.24 4.55 4.17
5 3.95 4.31 3.51 3.00 3.96 3.44 4.61 3.06 3.22 4.07 4.15
6 4.02 4.31 3.51 3.00 4.55 3.44 4.70 3.06 3.22 4.63 4.15
7 3.47 3.90 3.44 2.75 3.81 3.28 4.46 2.51 3.21 3.98 4.12
8 4.44 4.67 3.99 3.97 4.29 4.26 4.96 4.15 3.74 4.46 4.57
9 4.47 4.69 3.99 3.97 4.94 4.26 4.96 4.15 3.74 5.02 4.57
10 4.47 4.72 3.99 3.97 4.94 4.26 4.96 4.15 3.74 5.02 4.57
11 4.72 5.09 4.34 4.44 4.79 4.78 5.42 4.38 4.23 5.00 4.93
12 4.69 4.13 4.34 4.44 4.14 4.78 5.42 4.38 4.23 4.44 4.93
13 4.74 5.09 4.34 4.44 5.44 4.78 5.42 4.38 4.23 5.57 4.93
14 4.54 4.53 4.68 4.91 4.64 5.29 5.88 4.61 4.71 4.99 5.30
15 4.57 4.70 3.93 3.72 4.43 4.11 4.86 3.84 3.73 4.54 4.54
16 4.50 4.68 3.93 3.72 3.78 4.11 4.86 3.84 3.73 3.98 4.54
17 4.59 4.70 3.93 3.72 4.37 4.11 5.12 3.84 3.73 4.54 4.54
18 4.10 4.21 2.66 1.27 4.21 3.53 4.79 3.39 3.13 4.53 4.00
19 4.07 4.21 2.66 1.27 4.21 3.53 4.95 3.39 3.13 4.53 4.00
20 4.07 5.06 4.31 4.04 4.99 4.36 5.86 3.95 3.99 4.88 4.87
21 4.82 5.15 4.43 4.14 5.23 4.47 6.44 4.18 4.18 4.95 5.06
22 4.82 5.15 4.43 4.14 5.82 4.47 6.26 4.18 4.18 5.52 5.06
23 4.65 4.42 3.69 3.39 4.86 3.74 5.20 3.73 3.44 4.75 4.27
24 5.14 4.93 4.19 3.77 4.58 4.20 5.26 3.84 3.90 4.63 6.08
25 5.12 5.54 4.85 4.86 5.63 5.14 6.31 4.99 4.68 5.42 5.45
26 5.07 5.54 4.85 4.86 6.28 5.14 6.31 4.99 4.68 5.98 5.45
a clogPS, b Molinspirations, c OSIRIS property explorer, d HyperChem 7.0, e Sybyl X, f Marvin Sketch (ChemAxon)
15, g ChemSketch 2015, h Dragon 6.0, i Dragon 6.0, j Kowwin, k XlogP3).
The IVE-PLS procedure applied for the overall clogP matrix (X26 × 11) with the log k parameter
as a dependent variable selected Molinspiration, OSIRIS, Sybyl-X, ChemSketch, and MarvinSketch
software as significant contributors to the final model. Noticeably, not only the best inter-correlated
logP estimators were indicated, but also some balanced selection that prevents data overfitting was
observed by an evenly covering broader range of theoretical procedures. Subsequently, the averaged
values of the specified lipophilicity estimators were correlated with the experimental data (log k) with
the correlation coefficient r = 0.57 in the consensus clogP procedure.
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2.4. Variable-Oriented Similarity Evaluation
The descriptor-based similarity assessment was conducted using the PCA method on the pool
of variables derived from Dragon 6.0 software for the set of the investigated molecules. The initial
ensemble of the selected parameters (4885) was confined to 2733 variables because all columns with
nearly constant (standard deviation <10−4) or constant values and with missing values have been
excluded at the pre-processing stage. The resulting dataset was arranged into a matrix X with 26 rows
representing objects (molecules) and 2733 columns representing numerical variables (descriptors).
Significant variations of the examined set of carboxamide derivatives regarding their structure and
lipophilic profiles were visualized using centred and standardized data since the library of input
parameters contains variables of different orders of magnitude. The determination of the model
complexity expressed by the amount of principal components (PCs) is based on the percentage of
the modelled variance. In fact, PCA model with first four PCs described 79.50% of the total data
variance, while the first two PCs accounted for 61.91%. Not surprisingly, the examined analogues can
be classified into groups taking into account structural parameters –positional isomers are generally
grouped together as illustrated in Figure 3a. Obviously, the major structural variations of the remaining
ones from all were indicated for unsubstituted compound 1 (only hydrogen as an R substituent within
the phenyl ring) and tri-substituted compound 7. A noticeable separation of di-substituted compounds
with a CF3 moiety (21, 22 and 25, 26) was observed as well. Moreover, the indicated compounds
violate Ro5 as shown in Figure 3b. A detailed examination of the theoretical lipophilicity (calculated
in Sybyl-X) revealed that CF3 containing compounds are characterized with higher values of clogP
estimators (clogP > 5) and the experimental log k property as depicted in Figure 3a,c, respectively. On
the other hand, ‘a good drug-like score does not make a molecule a drug’ [34], but in the case of the
specified compounds, Ro5 violation can partially explain the observed decline in the activities.
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2.5. Biological Screening
As mentioned above, the biological activities of all the compounds were tested against
S. aureus ATCC 29213 as the reference and quality control strain and three clinical isolates of
methicillin-resistant Staphylococcus aureus (MRSA) [16,17]. For the reduction of risks, the evaluation of
the antimycobacterial activity of the compounds was performed against avirulent strain M. tuberculosis
ATCC 25177/H37Ra that has a similar pathology as M. tuberculosis strains infecting humans. This
model pathogen is commonly used in basic laboratory screening and represents a good model for
testing antitubercular agents [35]. M. kansasii DSM 44162 was used as the second strain representing
non-tuberculous mycobacteria. They cause, among other diseases, nontuberculous mycobacterial lung
infections, which are very common nowadays and can be indistinguishable from tuberculosis [36].
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In addition, all the compounds were investigated in relation to the inhibition of photosynthetic
electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. Antimicrobial activities were
expressed as minimum inhibitory concentrations (MICs), while PET inhibiting activity as an IC50
value (compound concentration causing 50% inhibition of PET). All the results are listed in Table 1.
Also, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl- tetrazolium bromide) assay of the most effective
antistaphylococcal and antitubercular compounds was conducted, and preliminary in vitro cytotoxicity
screening of the most effective antimicrobial compounds was performed using the human monocytic
leukemia THP-1 cell line. The cytotoxicity was evaluated as an LD50 value (LD50—lethal dose to 50%
of the cell population).
2.5.1. In Vitro Antistaphylococcal Susceptibility Testing
Only several compounds showed high potency against S. aureus ATCC 29213 as well as three
clinical MRSA strains. Especially N-(3-fluoro-5-methoxyphenyl)-1-hydroxynaphthalene-2-carbox-
amide (23) and N-(3,5-dimethylphenyl)-1-hydroxynaphthalene-2-carboxamide (13) showed excellent
activity against the reference (MICs = 1.60 and 3.43 µM, respectively) and the MRSA strains (MICs =
3.21 and 6.85 µM, respectively) comparable with or better than that of ampicillin. The potency revealed
by compounds 6 (R = 3,5-OCH3) and 11 (R = 2,5-CH3) against all four staphylococcal strains was
also high (MICs = 12.3/24.7 and 13.4/27.5 µM, respectively). Since the MICs of these compounds are
very similar, it can be speculated about the specific effectivity against Staphylococcus sp. In addition,
a standard MTT assay was performed on the most effective compounds. The MTT test can be used
to assess cell growth by measuring respiration. The MTT measured viability of bacterial cells less
than 70% after exposure to the MIC values for each tested compound is considered as a positive
result of this assay. This low level of cell viability indicates inhibition of cell growth by inhibition of
respiration [37,38]. It can be concluded the both selected compounds, i.e., 13 (R = 3,5-CH3, 19%) and
23 (R = 3-F-5-OCH3, 49%), showed significantly less than 70% viability of S. aureus ATCC 29213 at the
tested concentration equal to MICs (i.e., 3.43 µM (1 µg/mL) and 1.60 µM (0.5 µg/mL), respectively).
Due to the limited number of effective compounds, SAR cannot be clearly defined; however, it seems
that the activity increases with lipophilicity.
2.5.2. In Vitro Antimycobacterial Testing
Approximately half of the investigated compounds showed activity against both mycobacterial
strains. Compound (13, R = 3,5-CH3) demonstrated the highest activity against M. tuberculosis (MIC =
6.86 µM), while compound 23 showed the highest effectivity against M. kansasii (MIC = 12.0 µM). Also
compounds 14 (R = 2,4,6-CH3), 15 (R = 2-MeO-5-Me), 17 (R = 2-CH3-5-OCH3), 7 (R = 3,4,5-OCH3),
24 (R = 2-Cl-5-OCH3), 6 (R = 3,5-OCH3) and 23 (R = 3-F-5-OCH3) expressed high potency against M.
tuberculosis in the range from 13.0 to 25.6 µM, and compounds 1 (R = H [1]), 5 (R = 2,5-OCH3), 6 (R
= 3,5-OCH3), 13 (R = 3,5-CH3) and 9 (R = 3-CH3 [1]) showed high potency against M. kansasii in the
range from 15.2 to 28.8 µM. In addition, an MTT assay was performed with chosen compounds against
M. tuberculosis H37Ra. Both selected compounds 13 (R = 3,5-CH3, 32%) and 26 (R = 3-F-5-OCH3,
38%) demonstrated a significant decrease of the viability of M. tuberculosis H37Ra at the tested MIC
concentrations (i.e., 6.86 µM (2 µg/mL) and 25.6 µM (8 µg/mL), respectively), which means that the
compounds have potential to inhibit mycobacterial cell growth through respiratory inhibition [37,39].
The antimycobacterial activity of the compounds against M. tuberculosis was expressed as log(1/MIC),
and its dependence on lipophilicity expressed as log k is illustrated in Figure 4. When inactive
compounds are eliminated, in general, it can be stated that the activity slightly increases with increasing
lipophilicity. A similar dependence was also found for M. kansasii; therefore, it is not shown.
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2.5.3. In Vitro Cytotoxicity Assay
The preliminary in vitro cytotoxicity screening of selected compounds 1 (R = H), 6 (R = 3,5-OCH3),
11 (R = 2,5-CH3), 13 (R = 3,5-CH3) and 23 (R = 3-F-5-OCH3) was performed using the human monocytic
leukaemia THP-1 cells, see Table 1, and the toxicity of the compounds (LD50) was compared to that of
oxaliplatin (LD50 = 1.7 ± 0.6 µM) and camptothecin (0.16 ± 0.07 µM). An agent is considered cytotoxic
when it expresses a toxic effect on cells at concentrations up to 10 µM [40]; thus, 30 µM was used as
the highest concentration. It can be stated that even the treatment with 30 µM did not lead to any
significant toxic affect, i.e., LD50 > 30 µM. This observation is in a good agreement with the previous
result of antiproliferative assay published recently by Spaczynska et al. [10].
2.5.4. Inhibition of Photosynthetic Electron Transport (PET) in Spinach Chloroplasts
The values of the PET inhibition activity of the evaluated carboxanilides ranged from 8.19 to
569 µM, see Table 1. Compounds 13 (R = 3,5-CH3) and 23 (R = 3-F-5-OCH3) expressed the highest
PET-inhibiting activity (IC50 = 8.19 and 10.1 µM, respectively). With respect to this wide range of
activities, the trend of increasing PET activity with the increasing lipophilicity within a methoxylated
subset of compounds 3, 4 and 6 and a methylated subset of compounds 8–13 (correlation coefficient
r = 0.9569, n = 6) can be found, while the dependence of PET activity on log k within the combination
of substituents (compounds 15–26) is not so clear.
Additionally, we analysed ligand efficiency (LE) and ligand efficiency dependent lipophilicity
(LELP) for PET IC50 activities (see Table S4 in Supplementary Materials), because ‘lipophilicity alone
accounts only partially for the experimental efficacy‘. The widely accepted lower limit of LE is 0.3 [41].
Generally, less active compounds (PET IC50 >200) are characterized by lower values of LE <0.25. The
desired level for LELP is between 0 and 7.5; however, sometimes the range of −10 to 10 is suggested as
well [42]. In fact, all compounds in the analysed series 1–26 meet the LELP criterion. Despite LELP has
become a useful parameter to follow in the hit→lead optimization, it could not distinguish between
‘lean molecular mass’ and groups of real molecular bulkiness [41].
Based on the structural analogy of the investigated compounds and the presence of the amide
bond, it can be hypothesized that these compounds inhibit electron transport in PS II at the site of
QB plastoquinone, i.e., at the acceptor side of PS II similarly as previously published compounds,
such as ring-substituted salicylanilides and carbamoylphenylcarbamates [14,24,30], ring-substituted
hydroxynaphthalene-2-carboxanilides [1,31], N-alkoxyphenylhydroxynaphthalenecarboxamides [27],
8-hydroxyquinoline-2-carboxamides [26], and N-substituted 2-aminobenzothiazoles [43]. It is important
to underline, as mentioned above and previously [1,3,27,30], that really antimicrobially effective
compounds 6 (R = 3,5-OCH3), 13 (R = 3,5-CH3) and 23 (R = 3-F-5-OCH3) were also the most potent
PET inhibitors, see Table 1.
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2.6. Probability-Oriented Pharmacophore Modelling
Ligand-oriented studies for in silico assessment of the 3D-QSAR profile were performed with the
CoMSA to determine electron and/or steric factors that potentially contribute to the biological activities
(expressed in a logarithmic scale) of the investigated compounds [44]. Firstly, the q2cv performance
for the whole carboxamide dataset 1–26 was examined using the CoMSA approach. Secondly, the
external validation by splitting the molecular data into training/test subgroups using Kennard-Stone’a
algorithm [45] on descriptor-based data (X26×2733) was carried out to evaluate the predictive power of
the model with the standard deviation of the error of prediction (SDEP), the mean absolute error (MAE)
and q2test statistical metrics. Unfortunately, irrespective of the map size (20 × 20 to 50 × 50) the produced
q2cv/q2test outcomes were not satisfactory from the statistical point of view for the entire set of measured
compound activities. This phenomenon can be partially explained by the insufficient variability
among the empirically specified activity data—positional isomers are frequently characterized by the
same (or similar) response profiles (see Table 1). Relying exclusively on the training/test choice of
datasets is not acceptable in the advanced QSAR studies, therefore an additional evaluation called the
stochastic model validation (SMV) was employed as a kind of ‘perturbation’ procedure to scrutinize
the structure of the data. Thus, we recurrently sampled all pool of the systematically generated
training/test subpopulations (C826 ≈ 1.5 × 106) for activities revealing the greatest diversity. Obviously,
the resulting q2cv vs. q2test fluctuation pattern depicted the areas where higher modelling ability is
accompanied by the areas of lower model predictive power – preferential selection of training objects
produces the decline of the predictive abilities, but ‘the great advantage of the QSAR paradigm lies
not in the extrapolation’ with an ‘absolute measure’ of predictivity as was stated by Hansch [46].
Furthermore, the 26/8 training/test samples (3:1 ratio) were selected from regions of a fairly high model
ability and predictability to produce namely ‘consensus-based’ pharmacophore maps. Basically, an
even compound frequency distribution within the test subset population was observed; however,
mainly inactive compounds 2 (R = 2-OCH3), 8 (R = 2-CH3), 10 (R = 4-CH3), 14 (R = 2,4,6-CH3), 26 (R =
4-CH3-3-CF3), moderately active compound 11 (R = 2,5-CH3) and active compound 13 (R = 3,5-CH3)
outnumber the remaining ones. Roughly speaking, the ortho/para substituted carboxamide analogues
with electron-donating methyl- or methoxy-substituent(s) were preferentially chosen to the test set.
On the selected molecules of the training set, the IVE-PLS procedure was applied to eliminate variables
with the lowest stability abs(mean(b)/std(b)) values [47]. The cumulative sum of the common columns for
all of the investigated models was calculated and normalized to the range of <0,1>. The spatial pattern
illustrated in Figure 5 was produced with the pre-selected cut-off of 0.6 and further filtering of 60% of
the CoMSA descriptors that show a relatively small statistical significance for the modelled activity.
The relative contribution of each variable was weighted by the magnitude of the corresponding
regression coefficient b, where colours were used to indicate the influence of the selected charge (q)
descriptors on the activity profile to show not only the areas with a positive and/or negative activity
contribution (Figure 5a), but also four possible combinations of the mean regression coefficients and
charge values (Figure 5b). The detrimental impact on the investigated activity, mainly due to steric
and/or electrostatic factors, is indicated by dark spheres as shown in Figure 5a. Conversely, bright areas
illustrate the spatial pattern that was foreseen to be occupied by an atom or substituent to enhance the
molecule activity profile. It appeared that ortho and/or para substituents contribute unfavourably to the
activity of the analysed carboxamides, as was suggested by the dark areas nearby the phenyl ring in
Figure 5a. It seems that both positively and negatively charged groups at these positions (see Figure 5b)
have a detrimental impact on the observed activity of the compound. More or less, the same tendency
was observed among the positional isomers with ortho or para -OCH3 or –CH3 group substitution
in the phenyl ring (see the experimental data in Table 1). On the other hand, the obtained findings
demonstrate the significance of meta position, where the increase in the bulkiness appears to be a
favourable structural variation as shown in Figure 5a. In fact, the presence of negatively charged motifs
seem to contribute favourably (negative regression coefficients) to the observed activity response of
the investigated compounds as illustrated in Figure 5b. It corresponds quite well to the enormous
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enhancement of the activity of the compounds that was observed for meta methoxy-based analogues
(especially at position 5 of the phenyl ring), for instance, compounds 6 (R = 3,5-OCH3) and 23 (R =
3-F-5-OCH3). Moreover, the side chain elongation at position 5 with positively charged atom or group
may contribute favourably to the activity as depicted in Figure 5b.
In fact, probability-guided 3D-QSAR (CoMSA) modelling based on the iterative variable
elimination facilitated the visualization of the pharmacophore patterns that are potentially valid
for the activity of the analysed compounds.
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3. Experimental Section
3.1. Ch mistry—General Informati n
3.1.1. General Information
All reagents were purchased from Merck (Darmsta t, Germany) and Fisher Scientific (Waltham,
MA, USA). Reactions were performed using a StartSYNTH microwave lab station (Milestone, Sorisole
BG, Italy). Melting points were determined on a Kofler hot-plate apparatus (HMK Franz Kustner
Nacht BG, Dresden, Germany) and are uncorrected. Infrared (IR) spectra were recorded on a Smart
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MIRacle ATR ZnSe for Nicolet Impact 410 FT-IR spectrometer (Thermo Scientific, West Palm Beach,
FL, USA). The spectra were obtained by the accumulation of 64 scans with 2 cm−1 resolution in the
region of 4000–650 cm−1. All 1H- and 13C-NMR spectra were recorded on a JEOL ECZR 400 MHz
NMR spectrometer (400 MHz for 1H and 100 MHz for 13C, Jeol, Tokyo, Japan) in dimethyl sulfoxide-d6
(DMSO-d6). 1H and 13C chemical shifts (δ) are reported in ppm. High-resolution mass spectra
were measured using a high-performance liquid chromatograph Dionex UltiMate®® 3000 (Thermo
Scientific) coupled with an LTQ Orbitrap XLTM Hybrid Ion Trap-Orbitrap Fourier Transform Mass
Spectrometer (Thermo Scientific) equipped with a HESI II (heated electrospray ionization) source in
the positive mode.
3.1.2. Synthesis
General procedure: 1-Hydroxynaphthalene-2-carboxylic acid (5.3 mmol), and the corresponding
substituted aniline (5.3 mmol), were suspended in 30 mL of dry chlorobenzene. Phosphorous trichloride
(2.65 mmol) was added dropwise, and the reacting mixture was heated using infrared flask-surface
control of temperature at maximal allowed power 500 W and 130 ◦C in the microwave reactor for
15 min. The solvent was evaporated under reduced pressure. Subsequently, the solid residue was
washed with 2 M HCl, and the crude product was recrystallized from aqueous ethanol. All the studied
compounds are presented in Table 1.
Described anilides 1–4, 8–10 were characterized recently by Gonec et al. [1] and 5–7, 11–19, 21, 22,
24–26 by Spaczynska et al. [10].
N-(5-Bromo-2-methoxyphenyl)-1-hydroxynaphthalene-2-carboxamide (20). Yield 80%; Mp 157–159 ◦C; IR
(cm−1): 3429, 1626, 1599, 1589, 1576, 1530, 1502, 1481, 1409, 1388, 1331, 1273, 1243, 1206, 1174, 1141,
1125, 1087, 1029, 943, 866, 802, 784, 755, 720; 1H-NMR (DMSO-d6), δ: 13.43 (br. s, 1H), 10.49 (s, 1H),
8.33 (d, J = 8.2 Hz, 1H), 8.02–8.08 (m, 2H), 7.92 (d, J = 8.2 Hz, 1H), 7.67 (t, J = 7.3 Hz, 1H), 7.57–7.62
(m, 1H), 7.48 (d, J = 8.7 Hz, 1H), 7.41 (dd, J = 8.7, 1.8 Hz, 1H), 7.12 (d, J = 8.7 Hz, 1H), 3.88 (s, 3H);
13C-NMR (DMSO-d6), δ: 168.05, 158.20, 151.21, 136.08, 129.02, 128.68, 127.66, 127.61, 127.13, 126.01,
124.88, 123.81, 123.16, 118.65, 113.53, 111.32, 109.16, 56.20; HR-MS: [M + H]+ calculated 372.02298 m/z,
found 372.02444 m/z.
N-(3-Fluoro-5-methoxyphenyl)-1-hydroxynaphthalene-2-carboxamide (23). Yield 54%; Mp 95–98 ◦C; IR
(cm−1): 3439, 1639, 1600, 1592, 1575, 1538, 1468, 1448, 1410, 1388, 1348, 1323, 1276, 1249, 1197, 1174,
1142, 1060, 950, 824, 806, 757, 724, 676; 1H-NMR (DMSO-d6), δ: 13.66 (br. s, 1H), 10.51 (s, 1H), 8.34 (d,
1H, J = 8.2 Hz), 8.08 (d, 1H, J = 8.8 Hz), 7.92 (d, 1H, J = 8.2 Hz), 7.69 (ddd, 1H, J = 8.0, J = 6.8, J = 1.3 Hz),
7.59 (ddd, 1H, J = 8.3, J = 7.0, J = 1.2 Hz), 7.48 (d, 1H, J = 8.8 Hz), 7.34 (dt, 1H, J = 11.0, J = 1.2 Hz),
7.25 (t, 1H, J = 1.2 Hz), 6.67 (dt, 1H, J = 11.0, J = 1.2 Hz), 3.80 (s, 3H); 13C-NMR (DMSO-d6), δ: 169.62,
162.90 (d, J = 222.9 Hz), 160.43, 159.90, 139.81 (d, J = 13.7 Hz), 136.05, 129.28, 127.50, 126.02, 124.61,
123.09, 122.98, 117.93, 107.551, 103.36 (d, J = 1.4 Hz), 100.81 (d, J = 26.7 Hz), 97.69 (d, J = 24.5 Hz), 55.64;
HR-MS: [M + H]+ calculated 312.10305 m/z, found 312.10295 m/z.
3.1.3. Lipophilicity Determination by HPLC (Capacity Factor k/Calculated log k)
The lipophilicity determination was performed as described by Kapustikova et al. [48]. The log k
values of individual compounds are shown in Table 1.
3.1.4. X-ray Crystallography
The X-ray data for a colourless crystal of 11 was obtained at 120 K using a Bruker D8 QUEST
diffractometer equipped with a PHOTON 100 CMOS detector, using MoKα radiation (λ = 0.71073 Å).
The data collection and reduction were realized using the APEX3 software package [49]. The structure
of 11 was determined using direct methods (SHELXS) and refined by a full-matrix least-squares
procedure (SHELXL) [50]. All hydrogen atoms were found in the difference Fourier maps and refined
using a riding model with C–H = 0.95 Å for (CH)aromatic and 0.98 Å for (CH3), and with Uiso(H) =
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1.2 Ueq(CH), and 1.5 Ueq(CH3), respectively. The N–H and O–H hydrogen atoms were refined in a
similar manner using AFIX 43 and AFIX 83 instructions, respectively. The graphics were drawn and
additional structural calculations were performed by the DIAMOND [51] software. The description
of molecular and crystal structures is provided in Figure 2 and Figure S1, respectively, while crystal
data and structure refinement, selected bond lengths and angles and selected non-covalent interatomic
contacts can be found in Table 2, Tables S1 and S2, respectively.
Crystallographic data has been deposited with the Cambridge Crystallographic Data Centre
under CCDC deposition number 1939550. Copies of this information may be obtained free of charge
from the Director, CCDC, 12 Union Road, Cambridge CB2 1EY, UK (fax: +44-1223-336033; e-mail:
deposit@ccdc.cam.ac.uk or www:http://www.ccdc.cam.ac.uk).
3.2. Biological Testing
3.2.1. In Vitro Antibacterial Evaluation
The synthesized compounds were evaluated for in vitro antibacterial activity against
representatives of multidrug-resistant bacteria, clinical isolates of methicillin-resistant Staphylococcus
aureus (MRSA) 63718, SA 630 and SA 3202 [16,17] that were obtained from the National Institute of
Public Health (Prague, Czech Republic). S. aureus ATCC 29213 was used as the reference and quality
control strain. Ampicillin (Sigma, St. Louis, MO, USA) was used as the standard. The screening was
performed as described previously [2–4,7,16]. The results are summarized in Table 1.
3.2.2. In Vitro Antimycobacterial Evaluation
The evaluation of the in vitro antimycobacterial activity of the compounds was performed against
Mycobacterium tuberculosis H37Ra ATCC 25177 and M. kansasii DSM 44162 by means of the methodology
described recently [e.g., 1,3,4–6,15,43]. Isoniazid (Sigma) was used as the standard. The results are
summarized in Table 1.
3.2.3. MTT Assay
Compounds were prepared as previously stated and diluted in MH or MB broth for S. aureus to
achieve the desired final concentrations 0.5 and 1 µg/mL, respectively, for S. aureus ATCC 29213, and 2
and 8 µg/mL, respectively, for M. tuberculosis ATCC 25177/H37Ra. M. tuberculosis ATCC 25177/H37Ra
was suspended in ODAC supplemented MB at 1.0 McFarland and then diluted 1:10, using MB as a
diluent. The diluted mycobacteria (50 µL) were added to each well containing the compound to be
tested. S. aureus bacterial suspension in sterile distilled water at 0.5 McFarland was diluted 1:3. Inocula
were added to each well by multi-inoculator. Diluted mycobacteria in broth free from inhibiting
compounds were used as the growth control. All compounds were prepared in duplicate. Plates were
incubated at 37 ◦C for 7 days for M. tuberculosis and 24 h for S. aureus. After the incubation period, 10%
well volume of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reagent (Sigma)
was mixed into each well and incubated at 37 ◦C for 4 h in dark for mycobacteria and 1 h for S. aureus.
Then 100 µL of 17% sodium dodecyl sulphate in 40% dimethylformamide was added to each well.
The plates were read at 570 nm. The absorbance readings from the cells grown in the presence of
the tested compounds were compared with uninhibited cell growth to determine the relative percent
inhibition. The percent inhibition was determined through the MTT assay. The percent viability is
calculated through the comparison of a measured value and that of the uninhibited control: % viability
= OD570E/OD570P × 100, where OD570E is the reading from the compound-exposed cells, while OD570P
is the reading from the uninhibited cells (positive control). Cytotoxic potential is determined by a
percent viability of <70% [37–39,52].
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3.2.4. In Vitro Cytotoxicity Assay
Human monocytic leukaemia THP-1 cells were obtained from the European Collection of Cell
Cultures (ECACC, Salisbury, UK; Methods of characterization: DNA Fingerprinting (Multilocus
probes) and isoenzyme analysis). Cell toxicity was determined using a Cytotoxicity Detection KitPLUS
Lactate dehydrogenase (LDH) assay kit (Roche Diagnostics, Mannheim, Germany) according to the
manufacturer’s instructions, as described previously [1,3,4,43]. The results are summarized in Table 1.
3.2.5. Study of Inhibition of Photosynthetic Electron Transport (PET) in Spinach Chloroplasts
The PET-inhibiting investigation using chloroplasts from spinach (Spinacia oleracea L.) was
performed as described previously [1–4,24,30,43]. The results are summarized in Table 1. The
comparable IC50 value of the selective herbicide 3-(3,4-dichlorophenyl)-1,1-dimethylurea, DCMU
(Diuron®®, Sigma) as the standard was used. The results are shown in Table 1.
3.3. Theoretical Calculations
3.3.1. Molecular Modelling
In order to eliminate any potential data noise, that might have been introduced by pooling the data
sets from various sources, activity data were specified in the same laboratory. The set of in vitro activity
values (IC50) for the group of N-(methoxy/methyl-phenyl)-1-hydroxynaphthalene-2-carbox- amides
is listed in Table 1. The particular compound’s model was build using the CACTVS/csed molecular
editor, while the spatial geometry of the molecules was specified using a CORINA 3D generator. The
structural data conversion was performed with the (inter)change file format converter OpenBabel.
Sybyl-X 2.0/Certara software package running on an HP workstation with a Debian 6.0 operating
system was used to conduct the majority of the modelling simulations. The standard Tripos force field
(POWELL conjugate gradient algorithm) with a 0.01 kcal/mol energy gradient convergence criterion
and a distant dependent dielectric constant were employed to optimize the initial geometry of each
compound (MAXMIN2 module). The partial atomic charges were specified with the Gasteiger–Hückel
method implemented in Sybyl-X for the calculation of the electrostatic potential values. One 20-ordered
atom trial alignment on molecule 23 was used to cover the whole bonding topology in the maximal
common structure (MCS) using the atom FIT method, which is based on matching the positions of the
atoms between the corresponding atom pairs.
The SONNIA software was engaged in the CoMSA analysis to simulate 20 × 20 to 50 × 50
SOMs with a winning distance ranging from 0.2 to 2.0 [53,54]. In order to produce a 2D map of
the electrostatic potential for the superimposed molecules, a SOM network was employed using the
Cartesian coordinates of the molecular surfaces. Following the AA (Active Analogue) approach the
most active molecule 23 was selected as a reference structure (template molecule). The output maps
were reshaped into a 400- to 2500-element vector that was subsequently transformed by the PLS
method implemented in the MATLAB programming environment.
3.3.2. In Silico Lipophilicity Estimation, PCA and PLS analysis
A diverse set of freely or commercially accessible computer programs (see Table 3) can be employed
to specify the theoretical partition coefficient, for instance, AlogPS, milogP, ClogP, HyperChem logP,
MarvinSketch logP, ChemSketch logP, Dragon AlogP/MlogP, Kowwin and XlogP3.
Principal Component Analysis (PCA) is a linear projection method that condenses a
multidimensional data (organised in matrix Xmxn with the rows corresponding to m objects and
the columns corresponding to n parameters) into a few explanatory principal components (PCs) [55,56].
PCA is a classic method of data exploration, which allows to reduce data dimensionality, because a
restricted ensemble of the orthogonal PCs creates a basis of the lower-dimensional space.
Partial least squares (PLS) is a multivariate statistical method that can analyse the input data
with strong co-linearity and model, simultaneously a relationship between response data (dependent
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variable) Y and an ensemble of descriptors (independent variables) X is expressed briefly in the form
of the following formula:
Y = X b + e (1)
where b is a vector of the regression coefficients and e is a vector of errors.
3.3.3. Iterative PLS-based Variable Elimination
A set of descriptors that encode the molecular structure are usually (inter-)correlated significantly,
hence the relatively high data uncertainty is problematic in the rehearsal to assign and foreseen a
specified property. In fact, redundant descriptors can have a negative impact on the outcome of
the regression analysis; therefore, a selection of informative variables might noticeably improve
the PLS modelling. Despite the variable elimination/selection is an elaborate issue at least a few
chemometric algorithms have been proposed recently [57]. For instance, the iterative variable
elimination IVE-PLS that was effectively applied in the multidimensional-QSAR procedures can be
regarded as an enhancement of the single-step UVE procedure that was originally proposed by Centner
et al. for the specification of the variables to be eliminated [58]. Roughly speaking, the entire algorithm
is composed of four basic stages including:
Stage 1. Standard PLS analysis with LOO-CV to evaluate the performance of the PLS model
Stage 2. Elimination of a matrix column with the lowest abs(mean(b)/std(b)) value
Stage 3. Standard PLS analysis of the new matrix without the column eliminated in stage 2
Stage 4. Recurrent repetition of steps 1–3 to maximize the LOO parameter
4. Conclusions
Twenty-six variously methylated and methoxylated N-aryl-1-hydroxynaphthalene-
2-carboxanilides were evaluated against S. aureus, three clinical methicillin-resistant S. aureus
isolates, M. tuberculosis, and M. kansasii. The cytotoxic effects of the chosen effective compounds
were estimated on human monocytic leukaemia THP-1 cells using (LDH) assay. All the compounds
were tested as inhibitors of photosynthetic electron transport (PET) in spinach chloroplasts.
N-(3,5-Dimethylphenyl)-1-hydroxynaphthalene-2-carboxamide (13), N-(3-fluoro-5-methoxyphenyl)-
1-hydroxynaphthalene-2-carboxamide (23) and N-(3,5-dimethoxy- phenyl)-1-hydroxynaphthalene-
2-carboxamide (6) showed comparable with or even better activities than the used standards, such
as ampicillin and isoniazid. The MTT test of the most effective compounds against S. aureus and M.
tuberculosis suggested that a respiratory chain of both pathogens might be one of the possible sites of
action of these potential antimicrobial multitarget compounds. The effective compounds demonstrated
no cytotoxic effects up to the concentration LD50 >30 µM; therefore, the tested carboxanilides can
be considered as non-toxic agents for subsequent design of novel therapeutic agents. PCA was
employed to illustrate noticeable variations with respect to the molecular lipophilicity (theoretical
(clogP)/experimental (log k)) and Ro5 violations. Moreover, the ligand-oriented studies for the
assessment of the 3D-QSAR profile were carried out with the CoMSA to determine the electron and/or
steric factors that potentially contribute to the biological activities of the investigated compounds.
It seems that both positively and negatively charged groups at ortho and/or meta positions have a
detrimental impact on the observed carboxamide activity. More or less, the same tendency was
observed among the positional isomers with ortho or para –OCH3 or –CH3 group substitution in
the phenyl ring. On the other hand, the obtained findings demonstrate the significance of the meta
position, where an increase in the bulkiness appears to be a favourable structural variation. In fact, the
presence of negatively charged motifs seems to contribute favourably (negative regression coefficients)
to the observed activity response of the investigated compounds. It corresponds quite well with the
enormous increase of activity of compounds that was observed for the meta methoxy-based analogues
(especially at position 5 of the phenyl ring), for instance compounds 6 (R = 3,5-OCH3) and 23 (R =
3-F-5-OCH3).
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Supplementary Materials: The supplementary material is available online. Figure S1: Part of the crystal structure
of N-(2,5-dimethylphenyl)-1-hydroxynaphthalene-2-carboxamide (11), showing O–H···O and C–H···O non-covalent
contacts (green dashed lines). Symmetry code: (i) x+1/2,-y+1/2,z-1/2; Table S1: Selected bond lengths (Å) and angles
(◦) in 11; Table S2: Parameters (in Å, ◦) of selected non-covalent contacts within crystal structure of 11; Table S3:
Matrix of correlation coefficients (n = 26, α = 0.05) of linear relationships between particular partition coefficients
and experimental lipophilicity data (log k) for N-(methoxy/methyl-phenyl)-1-hydroxynaphthalene-2-carboxamides
1–26; Table S4: Physicochemical properties and calculated HAC, LE and LELP values of 1–26 analogues.
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